What Inrad does

INRAD, Inc. is a privately held medical device company headquartered in Kentwood, Michigan (Grand Rapids area), founded in 1981 and operating continuously for over 44 years. The company designs and manufactures interventional medical devices for the diagnostic and therapeutic procedural market, with a portfolio spanning core needle biopsy devices (PreciseCore with its no-throw firing mechanism, SelectCore with variable throw, and AccuCore), breast tissue markers (Trilogy and EasyMark product families with multiple shape configurations), ultrasound-enhanced needles (SampleMaster featuring HiLiter echogenic technology), FNA and aspiration biopsy needles (Chiba, Franseen, and Procytin-coated variants), coaxial introducers, guidewire introducer needles (Flashback, Arterial, Seldinger, Cournand styles), and accessories such as the reusable Aspiration Biopsy Syringe Gun and IV Decanter Set.

The company's underlying technology centers on proprietary physical device engineering: HiLiter ultrasound enhancement provides echogenic visibility at the needle tip, SureStop depth markers improve safety, Procytin anticoagulant coating minimizes microclots during FNA procedures, and Guard-Guide technology enables guidewire insertion. These innovations are protected by four granted US patents (8,197,419; 8,506,504; 8,192,369; 11,883,246) and a portfolio of registered trademarks. Products are engineered for ultrasound-guided percutaneous biopsies, breast lesion localization, thyroid FNA, prostate biopsy, and vascular access procedures.

INRAD operates a direct B2B sales model, selling exclusively to practicing physicians and healthcare facilities in the United States through phone, email, and fax ordering. The company offers complimentary evaluation samples to drive product trial and conversion, and maintains a confidential co-development program with practicing physicians and inventors for new product ideation. Revenue is generated through unit pricing of disposable single-use devices and reusable instruments, with no public pricing disclosure. The company has been self-financed since founding, with no external funding rounds, acquisitions, or public listing identified.

Name

Inrad

Legal name

INRAD, Inc.

Website

https://inradinc.com

Company type

Private

Founded year

1981

Operating status

Operating

Headcount range

101–250 employees

Short description

INRAD is a privately held Michigan-based medical device manufacturer founded in 1981 that designs and sells interventional products — including core needle biopsy devices, breast tissue markers, and ultrasound-enhanced needles — directly to US physicians in interventional radiology, breast biopsy, urology, and endocrinology.

Ownership category

akta.pro rank

Product category

Interventional Medical Devices

NAICS

Surgical and Medical Instrument Manufacturing (339112), Surgical Appliance and Supplies Manufacturing (339113)

SIC

Surgical & Medical Instruments & Apparatus (3841)

akta.pro primary industry

Interventional Radiology & Image-Guided Therapy Systems (HLAHABAG)

Keywords

• Biopsy needles
• Tissue markers
• Interventional radiology
• Medical device manufacturing
• Biopsy instruments

Headquarters

HQ city

Grand Rapids

HQ country

United States

HQ region

North America

Offices1 record

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Supply Chain, Operations, Personnel, Technology or R&D, Marketing or Sales

Revenue model

1. Medical Device Sales: INRAD generates revenue through the sale of interventional medical devices including biopsy needles, tissue markers, and access needles. Products are sold directly to healthcare providers with pricing based on order codes and quantities. The company offers disposable single-use products as well as reusable devices like the Aspiration Biopsy Syringe Gun.

Pricing tiers

Go-to-market motion2 records

Distribution channels2 records

Marketing channels4 records

Core offering

INRAD manufactures interventional medical devices for biopsy and tissue-marking procedures, including core biopsy needles, fine needle aspiration (FNA) needles, tissue/site markers, and access needles. The company also produces reusable and sterilizable instruments used by radiologists and other clinical specialists to obtain diagnostic tissue samples under imaging guidance. All products are sold as prescription-only medical devices to healthcare providers and institutions.

Product overview

INRAD is a medical device company specializing in interventional products for diagnostic procedures. The company offers a portfolio of biopsy devices including core needle biopsy instruments (PreciseCore, SelectCore, AccuCore), breast tissue markers (Trilogy, EasyMark), ultrasound enhanced needles (SampleMaster), aspiration and access needles (Chiba, Franseen, Aspiration), coaxial introducers, guidewire introducer needles, and accessories like the aspiration biopsy syringe gun and IV decanter. These products serve interventional radiology, breast biopsy, soft tissue biopsy, thyroid biopsy, prostate biopsy, and urology procedures.

Differentiator

Problem solved

Functional benefit

Brands

• Trilogy: Three unique shapes engineered for performance and visibility under all imaging modalities for breast tissue marking.
• EasyMark
• PreciseCore
• SelectCore
• AccuCore
• SampleMaster

Products and services

• Core biopsy needles Core biopsy needles designed for image-guided tissue sampling, featuring the PreciseCore no-throw design and HiLiter echogenic tip for visualization under ultrasound. Sold as prescription-only devices to radiologists and clinical institutions performing diagnostic biopsies.
• Fine needle aspiration (FNA) needles Fine needle aspiration needles used for diagnostic cytology sampling under imaging guidance. Sold as prescription-only devices to clinical specialists.
• Tissue/site markers Tissue or site markers used to mark biopsy locations for subsequent imaging, surgical, or follow-up reference. Sold as prescription-only devices to radiologists and clinical institutions.
• Access needles Access needles used to introduce biopsy or other interventional instruments into target anatomy. Sold as prescription-only devices to clinical specialists.
• Reusable and sterilizable biopsy instruments Reusable and sterilizable biopsy instrument platforms intended for repeated clinical use after appropriate sterilization, supporting clinical workflows that prefer reusable instrumentation. Sold as prescription-only devices to clinical institutions.

Segments4 records

Ideal customer profiles1 record

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature6 records

Partnerships

Three partnerships are on record, tiered core.

• Practicing PhysicianscoreStrategic or Co-development PartnerINRAD partners with practicing physicians who have expertise in their invention area. Physicians experience unique challenges in their practice and develop creative solutions that often result in the most successful products. INRAD provides a two-way confidential agreement that protects the inventor's idea while allowing INRAD to evaluate and potentially commercialize the product.
• Qualified Inventors with Medical Device ExpertisecoreStrategic or Co-development PartnerINRAD collaborates with qualified inventors who have medical device experience and domain expertise. The company will work with projects at any stage, taking an idea or concept through prototyping, research and development, regulatory submissions, manufacturing, and commercialization.
• Research InstitutionscoreStrategic or Co-development PartnerINRAD partners with research institutions that develop technologies in partnership with field experts. The company is open to projects serving any market size and specializes in one-time-use disposable medical device products for clinical settings.

Scale indicators2 records

Recent moves7 records

Expansion highlights5 records

Broad incumbents

• BD (Becton, Dickinson and Company): Global medical technology major with a strong biopsy and soft-tissue marker portfolio acquired through BD Bard. Directly comparable to INRAD in core needle biopsy, breast tissue markers, and FNA needles, but at vastly greater scale and with broader distribution.
• Stryker: Diversified medical device company with interventional and surgical product lines that overlap INRAD's procedural areas, including biopsy and access needles in some markets. Broader portfolio and global reach, but less specialized in soft-tissue biopsy than INRAD.
• Medtronic: Global medtech incumbent that owns the HiLiter, SureStop, SampleMaster, AccuMark, AccuPlace, and Guard-Guide trademarks referenced in INRAD's portfolio. Operates directly competing biopsy, marker, and interventional radiology product lines at far greater scale.
• B. Braun: Global medical device and pharmaceutical company with a meaningful interventional and needle portfolio, including regional anesthesia and biopsy needles. Comparable to INRAD in needle design and procedural use cases, but B. Braun serves a much wider clinical and geographic footprint.
• Merit Medical Systems: Public interventional medical device company with biopsy, drainage, and vascular access product lines. Competes with INRAD in interventional radiology procedure accessories, though its portfolio spans a much broader set of cardiology and oncology indications.
• Hologic: Women's health-focused medtech with a sizable breast biopsy franchise (ATEC, Celero, Brevera). Competes with INRAD in breast tissue marking and biopsy, but also operates adjacent imaging and diagnostic businesses that give it a much broader portfolio.

Others

• Cardinal Health: Major healthcare distributor that carries competing interventional and biopsy devices. Not a direct product competitor, but a relevant channel and competitor-by-proximity because INRAD sells direct while Cardinal Health serves as a critical distributor for many of its peers.

Direct peers

• Cook Medical: Privately held medical device manufacturer with deep interventional radiology and biopsy needle lines (Chiba, Franseen, coaxial, and guidewire introducers). Closely matches INRAD's FNA, coaxial, and access-needle product families and target specialists.
• Argon Medical Devices: Mid-sized interventional medical device company offering biopsy needles, drainage catheters, and vascular access products. Directly comparable to INRAD across soft-tissue core biopsy and FNA needles, with similar specialty-channel distribution.
• Mammotome (Devicor Medical Products): Specialist in breast biopsy devices and tissue markers, including vacuum-assisted and core needle systems. Direct competitor to INRAD's Trilogy and EasyMark breast tissue marker lines and core biopsy devices, serving the same radiology and breast surgery customers.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat4 records

Key risks5 records

Key highlights5 records

Customer concentration

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Inrad